Tri-aryl-substituted-ethane PDE4 inhibitors

Details for Australian Patent Application No. 2001242172 (hide)

Owner Merck Frosst Canada & Co

Inventors Friesen, Richard; Laliberte, Sebastien; Frenette, Richard; Girard, Mario; Hamel, Pierre; Guay, Daniel; Martins, Evelyn; Blouin, Marc; Cote, Bernard; Ducharme, Yves

Agent Spruson & Ferguson

Pub. Number AU-B-2001242172

PCT Pub. Number WO01/70738

Priority 60191668 23.03.00 US

Filing date 19 March 2001

Wipo publication date 3 October 2001

Acceptance publication date 27 January 2005

International Classifications

C07D 417/08 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

A61P 037/00 Drugs for immunological or allergic disorders

Event Publications

27 January 2005 Application Accepted

  Published as AU-B-2001242172

26 May 2005 Standard Patent Sealed

16 March 2006 Assignment Registered

  Merck Frosst Canada & Co. The patent has been assigned to Merck Frosst Canada Ltd.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001242173

2001242171